1. Home
  2. AMCR vs EXAS Comparison

AMCR vs EXAS Comparison

Compare AMCR & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amcor plc

AMCR

Amcor plc

HOLD

Current Price

$8.30

Market Cap

19.0B

ML Signal

HOLD

Logo Exact Sciences Corporation

EXAS

Exact Sciences Corporation

HOLD

Current Price

$101.75

Market Cap

11.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCR
EXAS
Founded
1926
1995
Country
Switzerland
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.0B
11.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AMCR
EXAS
Price
$8.30
$101.75
Analyst Decision
Buy
Buy
Analyst Count
7
20
Target Price
$10.40
$77.94
AVG Volume (30 Days)
21.1M
10.8M
Earning Date
02-03-2026
11-03-2025
Dividend Yield
6.32%
N/A
EPS Growth
N/A
N/A
EPS
0.32
N/A
Revenue
$17,401,000,000.00
$3,082,033,000.00
Revenue This Year
$57.16
$19.40
Revenue Next Year
$1.28
$13.51
P/E Ratio
$25.66
N/A
Revenue Growth
28.42
14.47
52 Week Low
$7.67
$38.81
52 Week High
$10.45
$101.95

Technical Indicators

Market Signals
Indicator
AMCR
EXAS
Relative Strength Index (RSI) 49.42 89.13
Support Level $8.18 $101.30
Resistance Level $8.39 $101.95
Average True Range (ATR) 0.14 0.38
MACD -0.02 -1.12
Stochastic Oscillator 39.29 72.00

Price Performance

Historical Comparison
AMCR
EXAS

About AMCR Amcor plc

Amcor is a global producer of plastic packaging primarily for the fast-moving consumer goods industry. About 90% of earnings are exposed to the flexible packaging business. This is soft disposable plastic for a variety of food, drink, healthcare, and hygiene products. The remainder of earnings are from the Latin and North American rigids business, which is primarily beverage bottling for the soft drink industry. Operating in more than 35 countries, Amcor has market share in its established regions of North America, Latin America, Europe, and Asia-Pacific. About half of group sales are derived from North America and the remainder is split equally between Western Europe and emerging markets. Australia and New Zealand sales make up less than 5% of group sales.

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

Share on Social Networks: